Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022

SELL
$119.57 - $139.07 $8.22 Million - $9.56 Million
-68,709 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$109.17 - $142.35 $850,543 - $1.11 Million
-7,791 Reduced 10.18%
68,709 $9.14 Million
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $967,076 - $1.12 Million
9,638 Added 14.41%
76,500 $8.27 Million
Q1 2021

May 17, 2021

BUY
$101.51 - $125.27 $324,324 - $400,237
3,195 Added 5.02%
66,862 $7.04 Million
Q4 2020

Feb 12, 2021

SELL
$85.88 - $105.36 $1.85 Million - $2.27 Million
-21,592 Reduced 25.33%
63,667 $6.57 Million
Q3 2020

Nov 12, 2020

BUY
$72.74 - $92.5 $84,596 - $107,577
1,163 Added 1.38%
85,259 $7.26 Million
Q2 2020

Aug 14, 2020

BUY
$48.02 - $79.04 $815,475 - $1.34 Million
16,982 Added 25.3%
84,096 $6.05 Million
Q1 2020

May 13, 2020

BUY
$36.95 - $62.95 $727,545 - $1.24 Million
19,690 Added 41.52%
67,114 $3.39 Million
Q4 2019

Feb 13, 2020

BUY
$47.06 - $56.64 $560,955 - $675,148
11,920 Added 33.57%
47,424 $2.69 Million
Q3 2019

Nov 13, 2019

SELL
$47.45 - $58.05 $323,134 - $395,320
-6,810 Reduced 16.09%
35,504 $1.69 Million
Q1 2019

May 15, 2019

BUY
$29.84 - $43.92 $1.26 Million - $1.86 Million
42,314 New
42,314 $1.72 Million
Q3 2018

Nov 13, 2018

SELL
$40.12 - $45.55 $3.27 Million - $3.71 Million
-81,490 Closed
0 $0
Q2 2018

Aug 13, 2018

BUY
$38.72 - $42.52 $462,704 - $508,114
11,950 Added 17.18%
81,490 $3.41 Million
Q1 2018

May 15, 2018

BUY
$39.4 - $47.39 $241,522 - $290,500
6,130 Added 9.67%
69,540 $2.82 Million
Q4 2017

Feb 14, 2018

BUY
$37.27 - $43.02 $2.36 Million - $2.73 Million
63,410
63,410 $2.61 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Amp Capital Investors LTD Portfolio

Follow Amp Capital Investors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.